Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.
about
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationIncreased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based StudyThe multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisPlasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple SclerosisTissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Production, regulation and role of nitric oxide in glial cells.Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.Plasmin system of Alzheimer's disease patients: CSF analysis.
P2860
Q24643613-278C30CE-B396-45F0-911D-0FCF082F3695Q33726132-86382230-9130-4527-AE25-567CE3D9C7E9Q33898964-BE3B2548-13A7-4F4D-9BE3-B66F497919C5Q35085079-781E465B-5E21-41C5-9A57-EB24D0BADA74Q35542637-EB1B5F70-6C0A-454E-A342-5B118630AA0CQ36327527-55A8425A-0BDA-4B26-B0E9-8A4B417E0399Q36913222-A285ECBE-FD9E-4008-B1B7-6C305722B191Q38655974-77AEEB3F-C824-446A-A752-D525CEDA4865Q38765008-AB6122E9-CBA5-42FC-AB07-55FB433F7279Q42981988-E1EF64B5-8A4A-4921-B43F-85FB09989875Q47846320-5339B75A-355B-4FC6-B776-95914396B7D6Q53327026-2B9361FC-7C51-4E3E-A9A4-767693EA41A3
P2860
Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@en
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@nl
type
label
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@en
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@nl
prefLabel
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@en
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@nl
P2093
P2860
P356
P1476
Cerebrospinal fluid plasminoge ...... nts with neurological disease.
@en
P2093
Akenami FO
Färkkilä M
Koskiniemi M
P2860
P304
P356
10.1136/JCP.50.2.157
P407
P577
1997-02-01T00:00:00Z